Brigham Hyde News Today

Plus: Atropos Health just raised $33 million for its radical AI approach to health data.

Atropos Health announced last week the successful completion of its $33 million Series B funding round.

Atropos Health raises $33 million in Series B funding to revolutionize healthcare with AI-powered clinical evidence generation, aiming to personalize medical decision-making and accelerate drug development.

Atropos Health raised $33 million for software that helps doctors, pharma companies and insurers figure out how patients react to treatments in the real-world.

The startup is focused on building out strategic partnerships with pharmaceutical companies and vertically integrated healthcare companies.

Atropos Health raises $33M on the heels of the adoption of its Generative AI platform (GENEVA OSTM) by healthcare institutions,

The company will use the funds to enter into strategic relationships with life sciences organizations focusing on oncology and specialty care.

Atropos Health partners with Google Cloud to rapidly generate insights from healthcare data using natural language AI, improving clinical decision making and advancing their mission to democratize access to real-world evidence.

Health system VC arms appear to have a lot more to offer to startups than traditional VC funds. Startup founders say that the tech pilots they launch with their health system partners end up being more effective because they are more incentive-aligned. For health systems, investing in a startup allows them to have a hand in shaping the tools they will eventually deploy across their enterprises to solve issues like burnout, payment delays and excessive hospital readmissions.

Arcadia's provider customers and life sciences users can leverage Atropos Health's datasets for value-based care and clinical decision-making.